Bianalisi Expands by Acquiring Lucea and Nobiliore

Deal News | May 16, 2025 | Finance Community IT - 3 Private Equity

Bianalisi Expands by Acquiring Lucea and Nobiliore

Bianalisi, an Italian integrated diagnostics operator owned by Charme Capital, has acquired two diagnostic center networks: Lucea, with nine sites in Puglia, and Nobiliore, with three sites in Lazio. These acquisitions bring Bianalisi's total to over 350 sites across 13 regions, serving over 15,000 patients daily. In 2024, Lucea recorded revenues of €9.3 million, while Nobiliore achieved €4.5 million. This expansion reinforces Bianalisi's presence as a sector leader in key regions. The acquisitions are intended to create operational and commercial synergies, complement the existing network, and enhance service offerings. Financial and legal advisors for the transaction included Orrick, Advant-Nctm, Deloitte, Sinergia Hub, Perno & Cremonese, Radice & Cereda, PedersoliGattai, and BDO. In addition, Bianalisi recently secured a €470 million financing from Carlyle and Arcmont Asset Management.

Sectors

  • Healthcare Services
  • Private Equity

Geography

  • Italy – The acquisitions and business expansions discussed are focused on Italian regions, primarily Puglia and Lazio.

Industry

  • Healthcare Services – The article revolves around Bianalisi's acquisition of healthcare service providers Lucea and Nobiliore, underscoring the expansion in diagnostic services.
  • Private Equity – Charme Capital, a private equity firm, is the owner of Bianalisi, indicating the involvement of private equity in the transaction.

Financials

  • €9.3 million – The revenue recorded by Lucea in 2024.
  • €4.5 million – The revenue recorded by Nobiliore in 2024.
  • €210 million – The 2024 revenue of Bianalisi.
  • €470 million – Financing acquired by Bianalisi from Carlyle and Arcmont Asset Management.

Participants

NameRoleTypeDescription
BianalisiAcquirerCompanyAn Italian integrated diagnostics operator owned by Charme Capital, involved in expanding its network through acquisitions.
LuceaTarget CompanyCompanyA network with nine diagnostic centers in Puglia, Italy.
NobilioreTarget CompanyCompanyA group with three diagnostic centers in Lazio, Italy.
Charme CapitalOwnerCompanyA private equity firm having control over Bianalisi.
OrrickLegal AdvisorCompanyProvided legal advice for Bianalisi.
Advant-NctmFinancial AdvisorCompanyProvided financial advice for Bianalisi.
DeloitteTax AdvisorCompanyProvided tax advisory services for Bianalisi.
Sinergia HubLegal AdvisorCompanyProvided legal support for Nobiliore.
Perno & Cremonese | Radice & CeredaTax AdvisorsCompanyProvided tax advisory services for Nobiliore.
PedersoliGattaiLegal AdvisorCompanyProvided legal consultation for Lucea.
BDOFinancial AdvisorCompanyProvided financial advisory services for Lucea.
Carlyle and Arcmont Asset ManagementFinancial ProvidersCompanyProvided €470 million financing to Bianalisi.